GlassScriptPhysician profile
Andrew S Blum
NPI 1629020532
$106,233.71
in general payments reported to CMS, 2019-2025
49 companies · $5,335 in 2025
The $5,335 reported for 2025 was more than what 86% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $8,477 · 2021: $17K · 2022: $30K · 2023: $3,220 · 2024: $2,524 · 2025: $5,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,711 · Consulting Fee: $4,210 · Travel and Lodging: $1,858 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,710.73 |
| Consulting Fee | $4,209.83 |
| Travel and Lodging | $1,857.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $82,275.46 | 2019-2024 | Xarelto |
| Stryker Corporation | $3,670.72 | 2019-2025 | Optablate, Spinejack, Omnicurve |
| Philips North America LLC | $2,646.45 | 2019-2024 | (Cn3) Zenition 90 |
| Medtronic USA, INC. | $2,250.00 | 2019 | |
| Bard Peripheral Vascular, INC. | $2,112.38 | 2021-2025 | Rotarexs 6 F X 135 Cm, Crosser Iq, Crosser Iq |
| Abbott Laboratories | $1,551.37 | 2019-2025 | Esprit |
| Cook Incorporated | $1,316.76 | 2023 | Zilver Ptx |
| Terumo Medical Corporation | $1,096.30 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,096.13 | 2019-2025 | Jardiance |
| Merit Medical Systems INC | $909.30 | 2019 | |
| W. L. Gore & Associates, INC. | $732.75 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis, Gore Dryseal Flex Introducer Sheath |
| Medtronic, INC. | $723.89 | 2022-2025 | Osteocool Rf Ablation System, Abre, Kyphon Express II Kyphopak Tray |
| Pfizer INC. | $705.84 | 2019-2025 | |
| Amgen INC. | $626.40 | 2019-2024 | Repatha |
| Medline Industries LP | $581.84 | 2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $567.63 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Becton, Dickinson and Company | $540.79 | 2025 | Rotarexs 6 F X 135 Cm |
| Chiesi USA, INC. | $519.84 | 2019-2025 | Kengreal, Cleviprex |
| Penumbra, INC. | $329.02 | 2020-2025 | Indigo System |
| Novartis Pharmaceuticals Corporation | $228.46 | 2019-2024 | |
| Boston Scientific Corporation | $206.20 | 2021-2025 | Embold Fibered, General - Therapies, Obsidio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $190.50 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $174.48 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $154.95 | 2019-2025 | Smart Port Ct, Alphavac |
| E.R. Squibb & Sons, L.L.C. | $123.99 | 2019-2020 | |
| Abiomed | $109.07 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $107.06 | 2019-2020 | |
| Cook Medical LLC | $105.74 | 2023-2025 | Rosen, Cook Celect, Zilver Ptx |
| Acist Medical Systems, INC. | $84.81 | 2024 | |
| Imperative Care, INC | $68.26 | 2024-2025 | Symphony Catheter, Prodigy Catheter |
| Regeneron Healthcare Solutions, INC. | $53.85 | 2019 | |
| Surmodics, INC. | $38.64 | 2022-2024 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Tactile Systems Technology INC | $38.17 | 2019-2021 | |
| Medtronic Vascular, INC. | $35.76 | 2019-2020 | |
| Ekos Corporation | $32.28 | 2019 | |
| Veryan Medical Incorporated | $28.33 | 2023-2024 | Biomimics 3d Vascular Stent System |
| Cardiva Medical, INC. | $24.44 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $22.48 | 2023 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $20.98 | 2020 | |
| Atricure, INC. | $19.70 | 2022 | |
| Lundbeck LLC | $19.65 | 2020 | |
| Icu Medical INC | $15.32 | 2024 | Clearguard Hd |
| Cardinal Health 200 LLC | $15.26 | 2019 | |
| Novo Nordisk INC | $14.68 | 2022 | |
| Elutia, INC. | $14.26 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $12.93 | 2022 | |
| Merck Sharp & Dohme LLC | $12.41 | 2021 | |
| Thrombolex, INC. | $8.18 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$500,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Blum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.